<rss version="2.0">
<channel>
<title>IBTimes.com RSS Feed - MDCO</title>
<description>International Business News - MDCO</description>
<link>http://www.ibtimes.com</link>
<copyright>All articles are copyrighted by IBTimes.com</copyright>

<image>
	<title>The International Business Times - Business News, Updated daily</title> 
	<width>400</width> 
	<height>100</height> 
	<link>http://www.ibtimes.com/</link> 
	<url>http://www.ibtimes.com/images/top_logo_ibt2_3.gif</url> 
</image>


  <item>
  <title>Earnings roundup: Torchmark, Seagate Tech</title>
  <description>Among the earnings stories for Wednesday, Oct. 22, from AP Financial News: McKINNEY, Texas (AP)--Life and health insurer Torchmark Corp. on Wednesday said its third-quarter profit fell 52 percent as it took a huge charge for investments that lost value as the market declined.</description>
    <link>http://www.ibtimes.com/articles/20081022/earnings-roundup-torchmark-seagate-tech.htm</link> 
  <pubDate>Wed, 22 Oct 2008 18:56:40 EDT</pubDate>
  </item>


  <item>
  <title>Outlook roundup: Blockbuster, Torchmark</title>
  <description>Among the earnings projection stories for Wednesday, Oct. 22, from AP Financial News: DALLAS (AP)--Movie rental company Blockbuster Inc. said Wednesday it is comfortable with third-quarter analyst expectations, though it did not give a specific profit or revenue outlook.</description>
    <link>http://www.ibtimes.com/articles/20081022/outlook-roundup-blockbuster-torchmark.htm</link> 
  <pubDate>Wed, 22 Oct 2008 18:42:17 EDT</pubDate>
  </item>


  <item>
  <title>Medicines Co. expects year loss on new drug cost</title>
  <description>Drug maker Medicines Co. said Wednesday it now expects to report a loss for 2008 due to the cost of developing a drug candidate created by Curacyte, a company it bought in August.</description>
    <link>http://www.ibtimes.com/articles/20081022/medicines-co-expects-year-loss-on-new-drug-cost.htm</link> 
  <pubDate>Wed, 22 Oct 2008 15:23:05 EDT</pubDate>
  </item>


  <item>
  <title>Medicines Co. posts narrower 3rd-qtr loss</title>
  <description>Drug maker Medicines Co. reported a narrower third-quarter loss Wednesday, as sales of its anti-clotting agent Angiomax climbed and acquisition costs fell.</description>
    <link>http://www.ibtimes.com/articles/20081022/medicines-co-posts-narrower-3rd-qtr-loss.htm</link> 
  <pubDate>Wed, 22 Oct 2008 14:50:02 EDT</pubDate>
  </item>


  <item>
  <title>FDA approves Medicines Co.'s blood-pressure drug</title>
  <description>Pharmaceutical maker Medicines Co. said Monday it received federal approval to market its drug Cleviprex for patients with difficult-to-treat high blood pressure.</description>
    <link>http://www.ibtimes.com/articles/20080804/fda-approves-medicines-co-s-blood-pressure-drug.htm</link> 
  <pubDate>Mon, 04 Aug 2008 10:21:42 EDT</pubDate>
  </item>


  <item>
  <title>Medicines hopeful on drug patent extension</title>
  <description>Drug developer Medicines Co. could gain a patent extension on its blood thinner product Angiomax, following a measure by the House of Representatives earlier this week.</description>
    <link>http://www.ibtimes.com/articles/20080625/medicines-hopeful-on-drug-patent-extension.htm</link> 
  <pubDate>Wed, 25 Jun 2008 14:07:40 EDT</pubDate>
  </item>


  <item>
  <title>Expanded use of Medicines blood thinner rejected</title>
  <description>Medicines Co. said Wednesday the Food and Drug Administration rejected its application to expand use of its blood thinner Angiomax to include acute coronary syndromes in emergency rooms.</description>
    <link>http://www.ibtimes.com/articles/20080528/expanded-use-of-medicines-blood-thinner-rejected.htm</link> 
  <pubDate>Wed, 28 May 2008 10:27:52 EDT</pubDate>
  </item>


</channel>
</rss>